Submission Details
| 510(k) Number | K173857 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2017 |
| Decision Date | November 06, 2018 |
| Days to Decision | 321 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K173857 is an FDA 510(k) clearance for the Elecsys Tacrolimus, a Enzyme Immunoassay, Tracrolimus (Class II — Special Controls, product code MLM), submitted by Roche Diagnostics (Indianapolos, US). The FDA issued a Cleared decision on November 6, 2018, 321 days after receiving the submission on December 20, 2017. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.1678.
| 510(k) Number | K173857 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2017 |
| Decision Date | November 06, 2018 |
| Days to Decision | 321 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | MLM — Enzyme Immunoassay, Tracrolimus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1678 |